The incidence and impact of lupus anticoagulants among patients in the intensive care unit

Authors

• Abdulaziz S. Aldawood, Department of Critical Care, King Fahad Hospital, PO Box 1149, Riyadh 11322, Kingdom of Saudi Arabia. Tel. +966 504486550. Fax. +966 (1) 2253379. E-mail: aldawooda{at}hotmail.com
• Mark Crowther, Department of Medicine, McMaster University, St. Joseph's Hospital, Ontario, Canada.
• Roman Jaeschke, Department of Medicine, McMaster University, St. Joseph's Hospital, Ontario, Canada.
• Ousama Dabbagh, Departments of Critical Care, King Fahad Hospital, Riyadh, Kingdom of Saudi Arabia.
• Khalid Alkhairy, Department of Pathology, King Fahad Hospital, Riyadh, Kingdom of Saudi Arabia
• Salim Baharoon, Departments of Critical Care, King Fahad Hospital, Riyadh, Kingdom of Saudi Arabia.
• Nazir Ahmed, Departments of Critical Care, King Fahad Hospital, Riyadh, Kingdom of Saudi Arabia.

Article Type

Brief Report

First Page

1994

Last Page

1995

Recommended Citation

Aldawood, Abdulaziz S.; Crowther, Mark; Jaeschke, Roman; Dabbagh, Ousama; Alkhairy, Khalid; Baharoon, Salim; and Ahmed, Nazir (2005) "The incidence and impact of lupus anticoagulants among patients in the intensive care unit," Saudi Medical Journal: Vol. 26: Iss. 12, Article 30.
DOI: https://doi.org/10.15537/1658-3175.3253